Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 102 | 2020 | 285 | 19.500 |
Why?
|
| Tobacco Use Disorder | 72 | 2020 | 104 | 16.310 |
Why?
|
| Adolescent Behavior | 51 | 2020 | 87 | 7.380 |
Why?
|
| Smoking Prevention | 37 | 2018 | 65 | 5.730 |
Why?
|
| Substance Withdrawal Syndrome | 18 | 2016 | 38 | 5.010 |
Why?
|
| Adolescent | 114 | 2020 | 1907 | 4.920 |
Why?
|
| Behavior, Addictive | 20 | 2020 | 41 | 4.310 |
Why?
|
| Commerce | 19 | 2020 | 36 | 4.090 |
Why?
|
| Personal Autonomy | 17 | 2015 | 29 | 4.080 |
Why?
|
| Smoking Cessation | 31 | 2020 | 121 | 3.770 |
Why?
|
| Nicotine | 19 | 2017 | 58 | 3.520 |
Why?
|
| Tobacco Products | 7 | 2020 | 16 | 3.150 |
Why?
|
| Tobacco Industry | 13 | 2014 | 17 | 2.660 |
Why?
|
| Male | 94 | 2020 | 8879 | 2.430 |
Why?
|
| Humans | 138 | 2020 | 19581 | 2.280 |
Why?
|
| Female | 93 | 2020 | 10007 | 2.280 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2016 | 20 | 2.010 |
Why?
|
| Minors | 6 | 2020 | 7 | 1.910 |
Why?
|
| Child | 42 | 2016 | 1378 | 1.820 |
Why?
|
| Surveys and Questionnaires | 20 | 2018 | 792 | 1.420 |
Why?
|
| Psychometrics | 16 | 2016 | 100 | 1.420 |
Why?
|
| United States | 31 | 2020 | 1927 | 1.270 |
Why?
|
| Brain | 9 | 2020 | 562 | 1.250 |
Why?
|
| Plants, Toxic | 10 | 2001 | 11 | 1.240 |
Why?
|
| Students | 7 | 2016 | 71 | 1.180 |
Why?
|
| Craving | 5 | 2016 | 9 | 1.080 |
Why?
|
| Young Adult | 15 | 2020 | 1347 | 0.990 |
Why?
|
| Adult | 33 | 2016 | 4926 | 0.980 |
Why?
|
| Nicotinic Agonists | 5 | 2015 | 24 | 0.970 |
Why?
|
| Smokers | 4 | 2020 | 14 | 0.950 |
Why?
|
| Health Education | 6 | 2008 | 50 | 0.910 |
Why?
|
| State Government | 3 | 2018 | 10 | 0.900 |
Why?
|
| Substance-Related Disorders | 5 | 2020 | 169 | 0.900 |
Why?
|
| Family | 3 | 2016 | 68 | 0.890 |
Why?
|
| Law Enforcement | 4 | 2011 | 12 | 0.880 |
Why?
|
| Drug and Narcotic Control | 5 | 2011 | 8 | 0.850 |
Why?
|
| Receptors, Nicotinic | 3 | 2020 | 44 | 0.830 |
Why?
|
| Water Pipe Smoking | 5 | 2020 | 6 | 0.820 |
Why?
|
| Parents | 5 | 2015 | 103 | 0.810 |
Why?
|
| Massachusetts | 19 | 2015 | 657 | 0.810 |
Why?
|
| Attitude to Health | 5 | 2011 | 79 | 0.800 |
Why?
|
| Counseling | 6 | 2015 | 115 | 0.780 |
Why?
|
| Motivation | 7 | 2016 | 71 | 0.750 |
Why?
|
| Health Promotion | 6 | 2018 | 140 | 0.730 |
Why?
|
| Child Behavior | 10 | 2010 | 30 | 0.700 |
Why?
|
| Population Surveillance | 2 | 2018 | 50 | 0.700 |
Why?
|
| Government Programs | 1 | 2018 | 5 | 0.650 |
Why?
|
| Prevalence | 8 | 2016 | 420 | 0.650 |
Why?
|
| Health Surveys | 8 | 2011 | 94 | 0.620 |
Why?
|
| Time Factors | 13 | 2018 | 1150 | 0.610 |
Why?
|
| Reproducibility of Results | 11 | 2015 | 499 | 0.600 |
Why?
|
| Asthma | 3 | 2016 | 103 | 0.580 |
Why?
|
| Cross-Sectional Studies | 9 | 2016 | 804 | 0.580 |
Why?
|
| Psychology, Adolescent | 6 | 2009 | 12 | 0.570 |
Why?
|
| Risk Factors | 13 | 2015 | 1592 | 0.560 |
Why?
|
| Government Regulation | 3 | 2011 | 11 | 0.540 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 5 | 0.530 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 8 | 0.530 |
Why?
|
| Receptors, Opioid, mu | 1 | 2015 | 4 | 0.530 |
Why?
|
| Longitudinal Studies | 10 | 2020 | 406 | 0.530 |
Why?
|
| Advisory Committees | 1 | 2015 | 18 | 0.520 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2010 | 40 | 0.520 |
Why?
|
| International Classification of Diseases | 3 | 2010 | 34 | 0.520 |
Why?
|
| Tobacco, Smokeless | 3 | 2011 | 5 | 0.520 |
Why?
|
| Marketing of Health Services | 3 | 2001 | 8 | 0.520 |
Why?
|
| Behavior Therapy | 1 | 2015 | 56 | 0.500 |
Why?
|
| Disease Progression | 2 | 2016 | 308 | 0.480 |
Why?
|
| Parietal Lobe | 1 | 2014 | 16 | 0.480 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 19 | 0.470 |
Why?
|
| Primary Health Care | 1 | 2015 | 149 | 0.470 |
Why?
|
| Age Factors | 9 | 2014 | 514 | 0.460 |
Why?
|
| Pediatrics | 3 | 2015 | 77 | 0.460 |
Why?
|
| Schools | 9 | 2020 | 59 | 0.440 |
Why?
|
| Middle Aged | 12 | 2016 | 5107 | 0.440 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2012 | 11 | 0.420 |
Why?
|
| Prospective Studies | 11 | 2016 | 1086 | 0.420 |
Why?
|
| Inhalation Exposure | 1 | 2012 | 8 | 0.420 |
Why?
|
| Guideline Adherence | 3 | 2009 | 89 | 0.410 |
Why?
|
| Child Welfare | 3 | 2008 | 14 | 0.400 |
Why?
|
| Habits | 1 | 2011 | 12 | 0.390 |
Why?
|
| Maze Learning | 1 | 2011 | 16 | 0.390 |
Why?
|
| Impulsive Behavior | 1 | 2011 | 5 | 0.390 |
Why?
|
| Drug Tolerance | 2 | 2011 | 10 | 0.390 |
Why?
|
| Quinoxalines | 1 | 2011 | 10 | 0.390 |
Why?
|
| Benzazepines | 1 | 2011 | 12 | 0.390 |
Why?
|
| Mental Recall | 3 | 2014 | 32 | 0.380 |
Why?
|
| Motor Activity | 1 | 2011 | 116 | 0.360 |
Why?
|
| Health Behavior | 1 | 2010 | 137 | 0.350 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 139 | 0.340 |
Why?
|
| Psychological Theory | 2 | 2015 | 13 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2017 | 188 | 0.340 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2009 | 10 | 0.340 |
Why?
|
| New Zealand | 4 | 2016 | 22 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 786 | 0.320 |
Why?
|
| Risk Assessment | 6 | 2014 | 536 | 0.310 |
Why?
|
| Universities | 1 | 2008 | 41 | 0.310 |
Why?
|
| Motion Pictures | 1 | 2007 | 7 | 0.300 |
Why?
|
| Social Control, Formal | 3 | 2001 | 5 | 0.290 |
Why?
|
| Physician's Role | 4 | 2003 | 38 | 0.290 |
Why?
|
| Ganglionic Stimulants | 1 | 2007 | 1 | 0.290 |
Why?
|
| Rats | 5 | 2017 | 583 | 0.290 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 484 | 0.290 |
Why?
|
| Odds Ratio | 7 | 2011 | 267 | 0.290 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 27 | 0.290 |
Why?
|
| Aged | 7 | 2016 | 4257 | 0.280 |
Why?
|
| Personality Inventory | 1 | 2006 | 15 | 0.280 |
Why?
|
| Marketing | 3 | 2014 | 5 | 0.280 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 55 | 0.280 |
Why?
|
| Tobacco Use Cessation | 2 | 2008 | 5 | 0.270 |
Why?
|
| Retrospective Studies | 5 | 2018 | 1769 | 0.260 |
Why?
|
| Social Class | 2 | 2014 | 38 | 0.250 |
Why?
|
| Receptors, Cholinergic | 1 | 2005 | 10 | 0.250 |
Why?
|
| Menthol | 2 | 2017 | 3 | 0.250 |
Why?
|
| Nurse's Role | 2 | 2011 | 40 | 0.250 |
Why?
|
| Peer Group | 3 | 2011 | 38 | 0.250 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 680 | 0.250 |
Why?
|
| Income | 2 | 2003 | 42 | 0.250 |
Why?
|
| Self-Assessment | 1 | 2004 | 9 | 0.250 |
Why?
|
| Models, Neurological | 1 | 2005 | 39 | 0.250 |
Why?
|
| Cohort Studies | 5 | 2009 | 779 | 0.250 |
Why?
|
| Manifest Anxiety Scale | 1 | 2004 | 2 | 0.250 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 218 | 0.240 |
Why?
|
| Taxes | 3 | 2000 | 3 | 0.240 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 17 | 0.240 |
Why?
|
| Proportional Hazards Models | 3 | 2010 | 230 | 0.240 |
Why?
|
| Locomotion | 3 | 2017 | 50 | 0.230 |
Why?
|
| Cyprus | 2 | 2016 | 2 | 0.230 |
Why?
|
| Child, Preschool | 3 | 2016 | 668 | 0.230 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 40 | 0.230 |
Why?
|
| Cues | 3 | 2015 | 26 | 0.230 |
Why?
|
| Social Environment | 3 | 2015 | 26 | 0.230 |
Why?
|
| Seasons | 1 | 2003 | 49 | 0.230 |
Why?
|
| Injections, Subcutaneous | 2 | 2015 | 18 | 0.220 |
Why?
|
| Adolescent Medicine | 1 | 2003 | 1 | 0.220 |
Why?
|
| Anxiety | 1 | 2004 | 131 | 0.220 |
Why?
|
| Pleasure | 2 | 2014 | 4 | 0.220 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 93 | 0.220 |
Why?
|
| Arousal | 2 | 2014 | 11 | 0.220 |
Why?
|
| Logistic Models | 5 | 2016 | 370 | 0.220 |
Why?
|
| Incidence | 3 | 2009 | 418 | 0.220 |
Why?
|
| Factor Analysis, Statistical | 3 | 2015 | 34 | 0.210 |
Why?
|
| Lebanon | 5 | 2020 | 5 | 0.210 |
Why?
|
| Causality | 2 | 2016 | 19 | 0.210 |
Why?
|
| Animals | 8 | 2017 | 7390 | 0.210 |
Why?
|
| Infant | 4 | 2012 | 504 | 0.200 |
Why?
|
| Brain Mapping | 3 | 2016 | 97 | 0.200 |
Why?
|
| Interviews as Topic | 3 | 2007 | 143 | 0.200 |
Why?
|
| Research Design | 2 | 2015 | 162 | 0.190 |
Why?
|
| Industry | 3 | 1996 | 9 | 0.190 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 706 | 0.190 |
Why?
|
| Age Distribution | 3 | 2015 | 79 | 0.190 |
Why?
|
| Sudden Infant Death | 2 | 2004 | 7 | 0.190 |
Why?
|
| Facility Regulation and Control | 1 | 2000 | 1 | 0.190 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2000 | 2 | 0.190 |
Why?
|
| Health Care Costs | 1 | 2001 | 40 | 0.190 |
Why?
|
| Marijuana Use | 1 | 2020 | 4 | 0.190 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 6 | 0.190 |
Why?
|
| Vaping | 1 | 2020 | 3 | 0.190 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 5 | 0.180 |
Why?
|
| Cluster Analysis | 2 | 2016 | 106 | 0.180 |
Why?
|
| Australia | 2 | 2010 | 41 | 0.180 |
Why?
|
| Private Sector | 1 | 1999 | 5 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 84 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 152 | 0.170 |
Why?
|
| Colorado | 1 | 2018 | 6 | 0.160 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 415 | 0.160 |
Why?
|
| Stress, Psychological | 3 | 2011 | 128 | 0.160 |
Why?
|
| Sex Distribution | 2 | 2008 | 75 | 0.160 |
Why?
|
| Age of Onset | 2 | 2008 | 46 | 0.160 |
Why?
|
| Perception | 2 | 2009 | 69 | 0.160 |
Why?
|
| Public Health | 2 | 2003 | 59 | 0.150 |
Why?
|
| Quebec | 2 | 2009 | 3 | 0.150 |
Why?
|
| Neural Pathways | 2 | 2016 | 42 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 296 | 0.150 |
Why?
|
| Brain Chemistry | 1 | 2017 | 25 | 0.150 |
Why?
|
| Public Policy | 2 | 1999 | 13 | 0.150 |
Why?
|
| Sex Factors | 3 | 2007 | 283 | 0.150 |
Why?
|
| Communication | 2 | 2015 | 145 | 0.140 |
Why?
|
| Visual Cortex | 1 | 2016 | 16 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2010 | 138 | 0.140 |
Why?
|
| Corpus Striatum | 1 | 2016 | 24 | 0.140 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 124 | 0.140 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 102 | 0.140 |
Why?
|
| Tobacco, Waterpipe | 1 | 2016 | 3 | 0.140 |
Why?
|
| Mississippi | 2 | 2015 | 25 | 0.140 |
Why?
|
| Relaxation | 2 | 2007 | 4 | 0.140 |
Why?
|
| Legislation as Topic | 3 | 1996 | 4 | 0.140 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 127 | 0.130 |
Why?
|
| Minisatellite Repeats | 1 | 2015 | 4 | 0.130 |
Why?
|
| Binge Drinking | 1 | 2016 | 13 | 0.130 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 9 | 0.130 |
Why?
|
| Depression | 3 | 2016 | 327 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 96 | 0.130 |
Why?
|
| Alleles | 1 | 2015 | 160 | 0.130 |
Why?
|
| Restaurants | 2 | 2018 | 12 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2012 | 367 | 0.120 |
Why?
|
| Genotype | 1 | 2015 | 263 | 0.120 |
Why?
|
| Legislation, Drug | 1 | 2014 | 5 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 200 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2011 | 1572 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 273 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 305 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 284 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 1995 | 112 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2013 | 24 | 0.110 |
Why?
|
| Corpus Callosum | 1 | 2013 | 17 | 0.110 |
Why?
|
| Netherlands | 1 | 2012 | 14 | 0.110 |
Why?
|
| Data Collection | 2 | 2005 | 113 | 0.110 |
Why?
|
| Academies and Institutes | 1 | 1992 | 5 | 0.110 |
Why?
|
| Ethics, Pharmacy | 1 | 1992 | 2 | 0.110 |
Why?
|
| Prisons | 1 | 2012 | 29 | 0.100 |
Why?
|
| Pharmacies | 1 | 1992 | 11 | 0.100 |
Why?
|
| Cartoons as Topic | 1 | 1991 | 1 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2012 | 75 | 0.100 |
Why?
|
| Reference Values | 2 | 2011 | 122 | 0.100 |
Why?
|
| School Nursing | 1 | 2011 | 3 | 0.100 |
Why?
|
| Indians, North American | 1 | 2011 | 9 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 28 | 0.100 |
Why?
|
| Bias | 2 | 2002 | 26 | 0.100 |
Why?
|
| Florida | 1 | 2011 | 17 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2011 | 58 | 0.100 |
Why?
|
| Varenicline | 1 | 2011 | 6 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2011 | 76 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 43 | 0.100 |
Why?
|
| Research | 1 | 2011 | 66 | 0.100 |
Why?
|
| Greece | 1 | 2010 | 1 | 0.100 |
Why?
|
| Exploratory Behavior | 2 | 2008 | 8 | 0.100 |
Why?
|
| Otitis Media | 2 | 2004 | 7 | 0.090 |
Why?
|
| United Kingdom | 1 | 2010 | 15 | 0.090 |
Why?
|
| Trust | 1 | 2011 | 19 | 0.090 |
Why?
|
| Physicians, Family | 2 | 2003 | 19 | 0.090 |
Why?
|
| Internet | 1 | 2011 | 150 | 0.090 |
Why?
|
| Manuals as Topic | 1 | 2009 | 4 | 0.090 |
Why?
|
| Hospitalization | 1 | 2012 | 346 | 0.090 |
Why?
|
| Linear Models | 2 | 2011 | 158 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 269 | 0.090 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2009 | 3 | 0.090 |
Why?
|
| New South Wales | 1 | 2009 | 2 | 0.090 |
Why?
|
| Life Style | 1 | 2009 | 99 | 0.080 |
Why?
|
| Imagination | 1 | 2008 | 2 | 0.080 |
Why?
|
| Alcoholism | 1 | 1990 | 90 | 0.080 |
Why?
|
| Truth Disclosure | 1 | 2008 | 13 | 0.080 |
Why?
|
| Personality Assessment | 1 | 2008 | 8 | 0.080 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 29 | 0.080 |
Why?
|
| Practice Management, Medical | 1 | 2008 | 9 | 0.080 |
Why?
|
| Probability | 1 | 2008 | 54 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 84 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2008 | 35 | 0.080 |
Why?
|
| Needs Assessment | 1 | 2008 | 45 | 0.080 |
Why?
|
| Cotinine | 1 | 2007 | 5 | 0.080 |
Why?
|
| Intention | 1 | 2007 | 13 | 0.080 |
Why?
|
| Psychological Tests | 1 | 2007 | 18 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 53 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 207 | 0.070 |
Why?
|
| Saliva | 1 | 2007 | 29 | 0.070 |
Why?
|
| Rats, Inbred WKY | 2 | 2017 | 9 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2007 | 54 | 0.070 |
Why?
|
| Mass Media | 2 | 2006 | 8 | 0.070 |
Why?
|
| Risk | 1 | 2007 | 130 | 0.070 |
Why?
|
| Nonprescription Drugs | 1 | 2007 | 4 | 0.070 |
Why?
|
| Endorphins | 1 | 2007 | 4 | 0.070 |
Why?
|
| Narcotics | 1 | 2007 | 8 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2007 | 20 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2007 | 30 | 0.070 |
Why?
|
| Serotonin | 1 | 2007 | 27 | 0.070 |
Why?
|
| Pregnancy | 2 | 2004 | 820 | 0.070 |
Why?
|
| Dopamine | 1 | 2007 | 40 | 0.070 |
Why?
|
| Consensus | 1 | 2007 | 72 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2011 | 142 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2006 | 64 | 0.070 |
Why?
|
| Accidents, Traffic | 1 | 1986 | 48 | 0.070 |
Why?
|
| Recurrence | 1 | 2006 | 179 | 0.070 |
Why?
|
| Attitude | 2 | 2003 | 41 | 0.070 |
Why?
|
| Homeostasis | 1 | 2007 | 130 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 113 | 0.060 |
Why?
|
| Financing, Organized | 1 | 2005 | 4 | 0.060 |
Why?
|
| Receptors, Muscarinic | 1 | 2005 | 6 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2005 | 14 | 0.060 |
Why?
|
| Self Report | 2 | 2016 | 129 | 0.060 |
Why?
|
| Intelligence | 1 | 2004 | 12 | 0.060 |
Why?
|
| Dizziness | 1 | 2004 | 8 | 0.060 |
Why?
|
| Nausea | 1 | 2004 | 16 | 0.060 |
Why?
|
| Nursing Methodology Research | 1 | 2003 | 24 | 0.060 |
Why?
|
| Family Characteristics | 1 | 2003 | 14 | 0.060 |
Why?
|
| Texas | 1 | 2003 | 26 | 0.060 |
Why?
|
| Personality | 1 | 2003 | 15 | 0.060 |
Why?
|
| Risk-Taking | 1 | 2003 | 58 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 70 | 0.050 |
Why?
|
| Interview, Psychological | 1 | 2002 | 17 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2002 | 27 | 0.050 |
Why?
|
| Politics | 1 | 2002 | 13 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2001 | 68 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2001 | 4 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 66 | 0.050 |
Why?
|
| Smoking Water Pipes | 1 | 2020 | 4 | 0.050 |
Why?
|
| Management Audit | 1 | 2000 | 1 | 0.050 |
Why?
|
| Cross-Cultural Comparison | 1 | 2000 | 8 | 0.050 |
Why?
|
| Crime | 1 | 2000 | 21 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 248 | 0.050 |
Why?
|
| Chewing Gum | 2 | 2007 | 3 | 0.040 |
Why?
|
| Rats, Inbred SHR | 1 | 2016 | 3 | 0.040 |
Why?
|
| Self Concept | 1 | 2016 | 47 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 1996 | 1 | 0.030 |
Why?
|
| Adenoidectomy | 1 | 1996 | 2 | 0.030 |
Why?
|
| Fires | 1 | 1996 | 3 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 16 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 7 | 0.030 |
Why?
|
| Middle Ear Ventilation | 1 | 1996 | 3 | 0.030 |
Why?
|
| Bronchitis | 1 | 1996 | 14 | 0.030 |
Why?
|
| Office Visits | 1 | 1996 | 12 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 309 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2008 | 181 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 24 | 0.030 |
Why?
|
| Health Policy | 1 | 1996 | 36 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1996 | 46 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1995 | 27 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 1996 | 70 | 0.030 |
Why?
|
| Pneumonia | 1 | 1996 | 81 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 5 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1995 | 8 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1995 | 17 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 1995 | 20 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 43 | 0.030 |
Why?
|
| Cough | 1 | 1996 | 127 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 25 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 33 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 1992 | 69 | 0.030 |
Why?
|
| Pattern Recognition, Visual | 1 | 1991 | 21 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2011 | 65 | 0.020 |
Why?
|
| Decision Making | 1 | 1992 | 100 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 122 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1990 | 396 | 0.020 |
Why?
|
| Role Playing | 1 | 1988 | 4 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 10 | 0.020 |
Why?
|
| Ethanol | 1 | 1990 | 172 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 82 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 114 | 0.020 |
Why?
|
| Tablets | 1 | 2007 | 5 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 9 | 0.020 |
Why?
|
| Social Behavior | 1 | 2005 | 23 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2005 | 61 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2003 | 11 | 0.010 |
Why?
|
| Organizational Policy | 1 | 2003 | 14 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 155 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2002 | 14 | 0.010 |
Why?
|
| Family Practice | 1 | 2003 | 88 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 51 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 162 | 0.010 |
Why?
|
| Focus Groups | 1 | 2002 | 88 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 253 | 0.010 |
Why?
|
| Emotions | 1 | 2002 | 88 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 1576 | 0.010 |
Why?
|